据悉，普思影医疗目标为研发国产的低液氦超导磁体技术，实现技术跨越。 其自主研发的PhaseXCool®技术，通过氦的气液相变实现了GM冷头与磁体内部关键部件的有效换热， 液氦在蒸发过程中吸收热量，再经GM制冷机冷凝回流，实现磁体的稳定运行。 近日，苏州普思影医疗（简称：普思影医疗）完成近亿元A轮融资，由常春藤资本领投，老股东东软资 本持续追加注资，小明投资跟投。 据天眼查，普思影医疗成立于2021年，专注于核磁共振成像设备（MRI）核心部件和整机系统的研发及 产业化运营，凭借多项颠覆性前沿技术创新，使传统磁共振成像超导磁体系统彻底摆脱对液氦战略资源 的过度依赖，并通过全中空水冷技术大幅提升磁共振整机成像速度。 其创始人倪志鹏博士围绕着"超导磁体"这一核心，在中国科学院等离子所、中科院电工所、飞利浦医 疗、东软医疗等机构任职期间，多次在超导磁体研发方面取得突破。2019年，他作为首席科学家，主导 科技部国家重点研发计划"低液氦低温超导磁体研发"项目。 来源：猎云网 截至目前，公司已完成3轮融资。 ...

Core Insights - Suzhou Pusi Ying Medical recently completed nearly 100 million yuan Series A financing, led by Ivy Capital, with continued investment from existing shareholder Neusoft Capital and participation from Xiaoming Investment [1] - The funding will accelerate the industrialization and expansion of the low helium siphon cooling technology PhaseXCool® in three main areas: medical MRI equipment, industrial magnetic single crystal superconducting systems, and precision scientific instruments [1] Company Overview - The founder, Dr. Ni Zhipeng, has a career focused on superconducting magnets, achieving breakthroughs in superconducting magnet research at institutions such as the Chinese Academy of Sciences and Philips Healthcare [1] - Pusi Ying Medical aims to develop domestic low liquid helium superconducting magnet technology to achieve technological advancement [1] Technology Breakthrough - The new generation of low liquid helium magnets eliminates excessive reliance on liquid helium by using a GM refrigerator secondary cold head (3-4K) as a cooling source, achieving efficient heat exchange for key components of the magnet [2] - The technology allows superconducting magnets to operate stably below 4.2K without liquid helium consumption, relying on a closed pipeline and heat exchanger for self-driven cooling [2] Structural and Cost Advantages - The new technology features structural design optimizations that reduce weight by nearly half, from 4.5-6 tons to approximately 3 tons, lowering manufacturing and installation barriers [2] - For hospitals, this means reduced infrastructure requirements, more flexible installation, and lower maintenance costs, while the overall operational costs can decrease by 50% due to significant savings on liquid helium [2]

Company Overview - Suzhou Pusi Medical recently completed nearly 100 million yuan in Series A financing, led by Ivy Capital, with continued investment from existing shareholder Neusoft Capital and participation from Xiaoming Technology [1] - The funding will accelerate the industrialization of the low helium siphon cooling technology PhaseXCool® in superconducting magnet devices, including MRI equipment, industrial magnetic single crystal systems, and precision scientific instruments [1] Technology and Innovation - The core breakthrough of Pusi Medical's new generation low helium magnet is the reduced reliance on liquid helium, utilizing a GM cooler secondary cold head (3-4K) as a cooling source [3] - The PhaseXCool® technology achieves effective heat exchange for key components of the magnet, allowing stable operation below 4.2K with significantly lower helium consumption [2][3] - The new technology features a closed-loop self-circulation system that eliminates helium leakage and quenching risks, reducing downtime recovery to one-third of traditional equipment [4] Market Potential - The global MRI equipment market is projected to grow from approximately $7.1 billion in 2024 to $10.3 billion by 2030, indicating a strong growth trajectory [6] - The low helium MRI market is expected to expand from $2.8 billion in 2024 to $5.9 billion by 2033, highlighting the demand for this innovative technology [6] - Pusi Medical plans to deliver the first batch of 3.0T low helium superconducting magnets for system testing to domestic clients by June next year, with industrial magnetic single crystal magnets expected by the end of the year [5]

Core Viewpoint - Pusiying Medical aims to deliver the first batch of 3.0T low-liquid helium superconducting magnets to major domestic clients by June next year, focusing on the industrialization of its PhaseXCool® technology in MRI equipment and other fields [2][9]. Financing and Technology Development - Pusiying Medical recently completed nearly 100 million yuan in Series A financing, led by Ivy Capital, with participation from existing shareholder Neusoft Capital and Xiaoming Technology. The funds will accelerate the industrialization of low-helium siphon cooling technology [3]. - The founder, Dr. Ni Zhipeng, has a strong background in superconducting magnet research, having led significant projects in this field [3][4]. Challenges of Traditional MRI Technology - Traditional MRI technology relies on liquid helium, which is a non-renewable and scarce resource, with over 95% of China's helium imported, primarily from the US and Russia. This poses risks to high-end medical equipment manufacturing in China [4]. - The cost of liquid helium has surged from 20-30 yuan per liter to 200-300 yuan per liter, leading to operational costs for a 3.0T MRI device reaching millions, comparable to manufacturing costs [4][5]. Innovations in Low-Helium Technology - Pusiying Medical's PhaseXCool® technology reduces reliance on liquid helium by using a GM cooler as a cold source, achieving efficient heat exchange for superconducting components [5][6]. - The new superconducting magnets can operate stably below 4.2K with significantly reduced liquid helium consumption, leading to a 50% reduction in overall operational costs [6][7]. Applications and Market Potential - The low-helium technology has potential applications beyond MRI, including in MR-Linac systems for cancer treatment and high-field MRI systems for brain research, which are currently expensive due to helium costs [8]. - The global MRI equipment market is projected to grow from approximately $7.1 billion in 2024 to $10.3 billion by 2030, with the low-helium MRI market expected to expand from $2.8 billion in 2024 to $5.9 billion by 2033 [9].